AVIEW COPD

Coreline Soft

AVIEW COPD gives COPD information based on a non-enhanced CT-scan of the thorax. Evaluation includes segmentation of lungs and lung lobes, low attenuation analysis, emphysema, vessel analysis, fissure integrity, air trapping, and airway measurements.

Information source: Vendor
Last updated: April 19, 2021

General Information

General
Product name	AVIEW COPD
Company	Coreline Soft
Subspeciality	Chest
Modality	CT
Disease targeted	COPD, Emphysema
Key-features	Lung lobe segmentation, Low Attenuation Analysis (LAA), Emphysema, Vessel Analysis, Fissure Integrity, Air Trapping, Airway Measurements, Pulmonary Vessels.
Suggested use	During: perception aid (prompting all abnormalities/results/heatmaps), During: interactive decision support (shows abnormalities/results only on demand), During: report suggestion

Technical Specifications

Data characteristics
Population	All adult chest CT
Input	Standard Thoracic CT: 120kV, 100mAs, <1.5mm, >16 channel
Input format	DICOM
Output	PDF report, 3D visualisations, Encapsulated Dicom
Output format	PDF, DICOM Structured Report
Technology
Integration	Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration CIS (Clinical Information System), Stand-alone third party application, Stand-alone webbased
Deployment	Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution
Trigger for analysis	Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time	1 - 10 minutes

Regulatory

Certification
CE	Certified, Class IIa , MDD
FDA	510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE)	AVIEW COPD provides CT values for pulmonary tissue from CT thoracic datasets. This software could be used to support the physician quantitatively in the diagnosis, follow up evaluation and documentation of CT lung tissue images by providing image segmentation of sub-structures in lung, lobe, airways and vessels, registration of inspiration and expiration which could analyze quantitative information such as air trapping volume, air trapped index, and inspiration/ expiration ratio. And also, volumetric and structure analysis, density evaluation and reporting tools. AVIEW COPD is also used to store, transfer, inquire and display CT data set on premise and as cloud environment as well to allow users to connect by various environments such as mobile devices and chrome browser.

Market

Market presence
On market since	11-2017
Distribution channels	RMS Medical Devices, Alma AI MARKETPLACE
Countries present (clinical, non-research use)	10+
Paying clinical customers (institutes)
Research/test users (institutes)	15+
Pricing
Pricing model	Subscription, One-off payment
Based on	Number of users, Number of installations

Evidence

Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers